GGHPX
Price
$7.16
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
VTPSX
Price
$133.38
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

GGHPX vs VTPSX

Header iconGGHPX vs VTPSX Comparison
Open Charts GGHPX vs VTPSXBanner chart's image
Goldman Sachs Intl Eq Div & Prem P
Price$7.16
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Idx InstlPls
Price$133.38
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GGHPX vs VTPSX Comparison Chart
Loading...
VS
GGHPX vs. VTPSX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGHPX is a StrongSell and VTPSX is a StrongSell.

FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 463B vs. GGHPX (153M). GGHPX pays higher dividends than VTPSX: GGHPX (3.49) vs VTPSX (3.30). GGHPX was incepted earlier than VTPSX: GGHPX (7 years) vs VTPSX (14 years). GGHPX is a more actively managed with annual turnover of: 18.00 vs. VTPSX (4.00). GGHPX has a lower initial minimum investment than VTPSX: GGHPX (0) vs VTPSX (100000000). VTPSX annual gain was more profitable for investors over the last year : 16.40 vs. GGHPX (11.42). VTPSX return over 5 years is better than : 19.17 vs. GGHPX (17.07).
GGHPXVTPSXGGHPX / VTPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years14 years-
Gain YTD2.3357.55231%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets153M463B0%
Annual Yield % from dividends3.493.30106%
Returns for 1 year11.4216.4070%
Returns for 3 years7.21-3.08-234%
Returns for 5 years17.0719.1789%
Returns for 10 yearsN/A35.40-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSLS6.050.17
+2.89%
ReShape Lifesciences Inc
CWK13.140.11
+0.84%
Cushman & Wakefield plc
RVNC5.80N/A
N/A
Revance Therapeutics
GL103.49-0.53
-0.51%
Globe Life
EBS8.77-0.35
-3.84%
Emergent Biosolutions